Pyrrolidine → HCID 77107435, compound
Reaction equation
[O:1]=[C:2]1[N:7]2[CH2:8][CH2:9][CH2:10][N:11]([CH2:12][C:13](O)=[O:14])[C:6]2=[CH:5][C:4]([O:16][CH2:17][C:18]2[CH:23]=[C:22]([F:24])[C:21]([F:25])=[C:20]([F:26])[CH:19]=2)=[N:3]1.[NH:27]1[CH2:31][CH2:30][CH2:29][CH2:28]1>>[O:14]=[C:13]([N:27]1[CH2:31][CH2:30][CH2:29][CH2:28]1)[CH2:12][N:11]1[CH2:10][CH2:9][CH2:8][N:7]2[C:2](=[O:1])[N:3]=[C:4]([O:16][CH2:17][C:18]3[CH:19]=[C:20]([F:26])[C:21]([F:25])=[C:22]([F:24])[CH:23]=3)[CH:5]=[C:6]12Participants
3
Procedure
The title compound was prepared by a procedure similar to that described for E13 starting from 2-(6-oxo-8-((3,4,5-trifluorobenzyl)oxy)-2,3,4,6-tetrahydro-1H-pyrimido[1,6-a]pyrimidin-1-yl) acetic acid and pyrrolidine.
Sources & evidence
- ORD record
- ord-735e1c2a3374429dbcd922fe71a014ab
- Source dataset
- uspto-grants-2016_03
- Patent number
- US09296755B2
Reaction notes
Loading…